Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement. Analysts caution that sector-specific punitive levies could jeopardise the entire deal, according to a CNBC report.Significant ambiguity surrounds the precise definitions and classifications of pharmaceutical goods within the framework of the trade truce finalised on Sunday. This agreement…
US President Donald Trump’s new blanket tariffs are scheduled to take effect on August 1, a move that experts…
Dow Futures were modestly higher early Monday, up by as much as 40 points before the open. The broader…
UnitedHealth Group Inc (NYSE: UNH) has reinstated its full-year guidance, but the management’s estimates hardly brought any good news…
On Monday, CK Hutchison announced ongoing discussions with a consortium regarding its $22.8 billion ports business. The talks involve incorporating…
European stock markets rallied on Monday, with the regional Stoxx 600 index climbing to a four-month high, as investors…
The United States and the European Union announced on Sunday a broad framework for a new trade agreement aimed…
Alibaba has announced its entry into the AI-powered wearables market with the launch of Quark AI Glasses, set for…